Skip to content

Tech Transfer & Scale-up

Explore how connected knowledge, risk-based readiness, and digital workflows support efficient technology transfer and process scale-up across sites and lifecycle stages.

Last Updated: August 04, 2026

Tech Transfer in Life Sciences

Tech Transfer & Scale-up turns development knowledge into a manufacturing process that another team, site, or partner can execute consistently. Success depends on more than handing over documents: teams must transfer the scientific rationale behind process parameters, material attributes, analytical methods, risks, controls, and acceptance criteria. This guide explains how connected knowledge, risk-based readiness, structured digital workflows, and continued process learning can reduce rework and protect product quality as processes move between scales and sites.

Talk to a Tech Transfer Expert

Moving process knowledge from development to manufacturing

Technology transfer is the controlled movement of product, process, analytical, and manufacturing knowledge from a sending unit to a receiving unit. It may support scale-up from development to commercial manufacturing, a transfer between internal sites, or a sponsor-CDMO relationship. In every case, the receiving team needs enough context to reproduce the process, understand its limits, manage risk, and explain the basis for critical decisions.

Many transfer problems begin before the formal handoff. When development knowledge is fragmented across spreadsheets, reports, email threads, and individual experts, the transfer package may contain results without the rationale that produced them. The article on how technology transfer inefficiencies drive up costs describes how incomplete knowledge flow, manual data handling, and weak traceability create delays and repeated work. The video on hidden technology transfer risks reinforces the same issue: static documents provide a snapshot, while the receiving team needs a shared understanding of the process.

Scale-up adds another layer of uncertainty. Equipment, batch size, operating conditions, sampling, and process dynamics may change as the process moves toward commercial manufacturing. Teams need to identify which material attributes and process parameters may influence quality at the new scale, assess the associated risks, and confirm that the control strategy remains appropriate. A structured Quality by Design framework connects the quality target, CQAs, CPPs, risk assessments, studies, and controls so that scale-up decisions remain tied to development knowledge.

Readiness should therefore be evaluated before execution. A transfer plan can define scope, roles, deliverables, data requirements, risk-review points, method transfer needs, training, engineering or demonstration activities, acceptance criteria, and escalation paths. The digital toolbox for effective technology transfer highlights how integrated digital methods can improve process design, control, monitoring, and consistent execution. The webinar on the toolbox for an effective transfer provides additional guidance on bringing those capabilities together.

Risk management keeps the plan focused. Teams can use quality risk management tools to identify failure points, analyze cause-and-effect relationships, and prioritize controls. Risks should remain linked to owners, actions, evidence, and decisions. The webinar on turning CMC risk decisions into traceable action plans addresses the common gap between identifying a risk and maintaining visible follow-through across development, scale-up, and transfer. NEW-[BP]-Digitalizing-QbD-Frameworks-Setting-Tech-Transfers-Up-for-Success

Digital workflows improve continuity by maintaining one governed knowledge base for the sending and receiving teams. Moving CMC development beyond Excel can reduce version conflicts and manual reconciliation, while digital transformation in sponsor-CDMO transfers supports communication and collaboration across organizational boundaries. The goal is a traceable flow of knowledge, not a larger collection of files.

Transfer continues after initial execution. Findings from engineering runs, qualification, investigations, and routine manufacturing should update the risk assessment, control strategy, and knowledge base. Real-time process monitoring and digital continued process verification help teams detect trends and compare performance as process experience grows. This closes the loop between development, scale-up, transfer, and commercial control.

Frequently Asked Questions

It is the controlled transfer of product, process, analytical, and manufacturing knowledge from a sending organization or site to a receiving one so the process can be executed consistently and maintained in control.

It should provide the process and product definition, material and equipment requirements, analytical methods, critical attributes and parameters, risk assessments, control strategy, supporting studies, acceptance criteria, unresolved issues, and the rationale behind key decisions.

Scale-up evaluates how changes in equipment, batch size, operating conditions, and process dynamics may affect product quality. The resulting knowledge, risks, limits, and controls become part of the transfer to the receiving manufacturing team.

Common causes include fragmented knowledge, incomplete rationale, inconsistent data, unclear ownership, late risk identification, version conflicts, and weak communication between sending and receiving teams. Better pharmaceutical development through connected CMC knowledge can reduce these gaps before transfer begins.

They can connect process knowledge, risks, actions, controls, approvals, and transfer evidence in a governed environment. This helps teams collaborate on current information and maintain traceability from development decisions through receiving-site execution. The webinar on reimagining technology transfers with automation and AI assessments explores this digital-first model.

Confirm that required knowledge and documents are current, critical risks have controls and owners, methods and equipment requirements are understood, training is complete, acceptance criteria are agreed, open actions are visible, and the receiving team can explain and execute the process.

CPV provides ongoing process and quality data after transfer. Trending can identify drift, support investigations, compare performance across scales or sites, and show whether the process remains within the intended control strategy. The webinar on turning CPV trends into risk and defensible change shows how those insights can feed lifecycle decisions.

Conclusion

Effective Tech Transfer & Scale-up preserves the connection between scientific knowledge and manufacturing execution. Teams need a current control strategy, visible risks and actions, agreed readiness criteria, and a receiving organization that understands both the process and its rationale. Start by mapping where knowledge currently breaks between development and manufacturing, then pilot a governed workflow that connects transfer requirements, risks, evidence, approvals, and learning. For a concise overview, watch Tech Transfer Inefficiency: Where CMC Timelines Bleed Cost.

Talk to a Tech Transfer Expert